ctrl K

AI Score

Unlock

AN2 Therapeutics Inc. (ANTX)

AI Score

Unlock

1.41

0.03 (2.17%)

At close: Apr 02, 2025, 3:59 PM

1.33

-5.67%

After-hours: Apr 02, 2025, 06:36 PM EDT

AN2 Therapeutics Income Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	77K	n/a	n/a	n/a
Gross Profit	n/a	-77K	n/a	n/a	n/a
Operating Income	-69.64M	-42.26M	-21.57M	-7.28M	-5.18M
Interest Income	n/a	1.35M	69K	3K	n/a
Pretax Income	-64.73M	-40.96M	-21.54M	-13.6M	-5.63M
Net Income	-64.73M	-41.47M	-21.47M	-13.6M	-5.63M
Selling & General & Admin	14.76M	12.75M	4.67M	1.26M	289K
Research & Development	54.87M	29.51M	16.91M	6.02M	4.89M
Other Expenses	n/a	-45K	-38K	-6.32M	n/a
Operating Expenses	69.64M	42.26M	21.57M	7.28M	5.18M
Interest Expense	n/a	514K	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	287.27K
Cost & Expenses	69.64M	42.26M	21.57M	7.28M	5.18M
Income Tax	n/a	514K	-69K	-3K	-31.07K
Shares Outstanding (Basic)	23.6M	19.4M	18.74M	18.74M	18.74M
Shares Outstanding (Diluted)	23.6M	19.4M	18.74M	18.74M	18.74M
EPS (Basic)	-2.74	-2.14	-1.15	-0.73	-0.3
EPS (Diluted)	-2.74	-2.14	-1.15	-0.73	-0.3
EBITDA	4.9M	-42.26M	n/a	-6.32M	n/a
EBIT	-64.73M	-40.96M	-21.54M	-13.6M	-31.07M
Depreciation & Amortization	69.64M	77K	21.57M	7.28M	31.07M